MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma.

Autor: Zhan Y, Guo J, Yang W, Goncalves C, Rzymski T, Dreas A, Żyłkiewicz E, Mikulski M, Brzózka K, Golas A, Kong Y, Ma M, Huang F, Huor B, Guo Q, da Silva SD, Torres J, Cai Y, Topisirovic I, Su J, Bijian K, Alaoui-Jamali MA, Huang S, Journe F, Ghanem GE, Miller WH Jr, Del Rincón SV
Jazyk: angličtina
Zdroj: The Journal of clinical investigation [J Clin Invest] 2024 Apr 15; Vol. 134 (8). Date of Electronic Publication: 2024 Apr 15.
DOI: 10.1172/JCI181338
Databáze: MEDLINE